Toxicological investigation of alpha-isopropyl-alpha-(2-dimethylaminoethyl)-1-naphthylacetamide (Naphthypramide, DA 992): a new anti-inflammatory agent.
D000014:Abnormalities, Drug-Induced; D000577:Amides / Q000633:toxicity*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000633:toxicity*; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D004361:Drug Tolerance; D005260:Female; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D009281:Naphthalenes / Q000633:toxicity*; D009929:Organ Size; D010653:Phenylbutazone / Q000633:toxicity; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced
D000577:Amides; D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D009281:Naphthalenes; D010653:Phenylbutazone